Cell-mediated immunity plays a critical role in recovery from herpes simplex virus type 1 (HSV) infections (17) , and several models have been described for identifying specific cell-mediated immunity responses to HSV. Antiherpetic activity by macrophages (21) , natural killer cells (12) , delayed-type-hypersensitivity-mediating T cells (14) , and cytotoxic T lymphocytes (CTL) (11) has been described. Of these, HSV-specific CTL activity has proven the most difficult to demonstrate. Either pretreatment with cyclophosphamide or in vitro cultivation is necessary to demonstrate HSV-specific CTL activity in lymph nodes (16) and spleens (11) of infected animals. Therefore, it has been suggested that HSV-specific CTL induction is regulated by a suppressor cell which is inactivated by either in vitro cultivation or low-dose cyclophosphamide treatment (11, 16) . Although limiting dilution analysis of HSV-specific CTL precursors has provided additional indirect evidence of suppression (18) , no direct evidence of HSV-specific CTL suppression has been forthcoming despite reports of suppressor cells and factors regulating HSV-specific delayedtype hypersensitivity (15) and lymphoproliferative responses (8) .
In this communication suppressor factors are described which regulate the in vitro induction of HSV-specific CTL. HSV-immune splenocytes stimulated with HSV produced suppressive supematant fluids which when fractionated on a gel filtration column contained multiple suppressor activities. One of these fractions exhibited both HSV-specific and genetically restricted activity.
MATERIALS AND METHODS
Viruses, cells, and mice. HSV strain KOS was propagated in HEp-2 cells by the method of Bone and Courtney (4). Viral stocks used had an infectivity titer of 4 x 108 PFU/ ml. The virus was UV inactivated by exposing 0.5 ml of the viral stock to a germicidal lamp (Sylvania Electric Products) at a distance from the lamp of 3 cm for 2 (11) . Splenocytes were adjusted to 4 x 106 cells per ml in RPMI 1640 containing 5% heat-inactivated fetal calf serum (GIBCO Laboratories), 7 mM glutamine, penicillin (100 ,u/ml), streptomycin (100 ,ug/ml), gentamicin (50 ,ug/ml), and 5 x 10-5 M 2-mercaptoethanol. For bulk cultures 10 ml of the cell suspension was added to 100-mm culture plates (Coming Glass Works, Coming, N.Y.), and for microcultures 0.1 ml of the suspension was added to each well of a flat-bottomed, 96-well plate (Corning). HSV (multiplicity of infection was 1.0 before UV inactivation) or influenza (100 hemagglutination units) was added to each culture in complete medium to a final volume of 15 complement (C') depletion. Nylon-wool-purified cells were prepared by adhering 107 splenocytes to 0.5 mg of nylon wool in a 10-ml disposable syringe (11) . The nonadherent cells were eluted with 15 ml of prewarmed RPMI 1640. The yield from the column was approximately 35%, and the eluted cells were >99% Thy 1+, immunoglobulin negative (data not shown). Antibody and complement depletion was performed as detailed elsewhere (11) . Briefly 10 cells were incubated with 1.0 ml of anti-Thy 1.2 antiserum (Cedarlane Laboratories) for 45 min on ice. The cells were washed once with cytotoxicity medium (Cedarlane) and then resuspended in 1.0 ml of rabbit C (Cedarlane). After 30 min of incubation, the cells were rinsed several times with cytotoxicity medium and then resuspended in fresh RPMI 1640 containing 5% fetal calf serum.
Preparation of culture supernatant fluids. Supernatant fluids from HSV-immune cultures were collected at various intervals after initiation of the bulk culture. The cells were pelleted by centrifugation (500 x g for 15 min) and discarded. The supernatant fluid was dialyzed overnight against RPMI 1640, filter sterilized (0.2 ,uM Acrodisc; Gelman Sciences, Inc., Ann Arbor, Mich.), and stored frozen at -70°C. Serum-free 5-day supernatants for biochemical fractionations were prepared by incubating the splenocytes for 3 days in complete medium, pelleting the cells, and then suspending the cells in serum-free RPMI 1640. After an additional 48-h of incubation, the serum-free conditioned medium was concentrated by ultrafiltration on an Amicon PM-10 membrane (Amicon Corp., Lexington, Mass.) and dialyzed overnight against phosphate-buffered saline (pH 7.2) containing 0.05% polyethylene glycol (3350; Sigma Chemical Co., St. Louis, Mo.).
Assay of culture supernatant fluids. Supernatant fluids were assayed for suppressive activity by adding them at initiation to HSV-stimulated, HSV-immune splenocyte microcultures. In some experiments, the supernatant was added at various intervals after culture initiation. (Table 1 ). The supernatant fluids from these cultures also contained a nondialyzable heat-labile suppressor activity for HSV-specific CTL induction (HSV-SF). However, production of the suppressor activity did not always correlate with CTL induction as CTL-negative cultures did produce HSV-SF (data not shown). Production of this suppressor activity increased throughout the culture period (Fig. 1) ; however, statistically significant (P < 0.01) levels of suppressor activity were noted only with HSV-SF obtained after 3 days of incubation. The supernatant fluids from normal, HSV-stimulated normal, HSV-stimulated influenza-immune, or unstimulated immune splenocytes were neither suppressive nor enhancing (data not shown). 
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a HSV-immune splenocytes were incubated for 3 days with HSV antigens in bulk cultures and then separated into various subpopulations based on adherency to plastic and nylon wool. The cells were incubated for an additional 3 days in fresh media. The supernatants from these cultures were harvested and assayed for HSV-SF activity as described in Table 1 , footnote a. In the case of antibody and C treatments, splenocytes were treated on day 0 before antigen stimulation. The supernatants were harvested on day 6. b The treatment procedures are described in detail in the text. Plastic adherent cells were those cells which remained on the culture dishes after the dishes were rinsed with warm media on day 3. Plastic nonadherent cells were those collected by rinsing the plates with warm media.
c % Suppressor activity of supernates (Experimental/control) x 100%. The no-treatment control (None) reduced CTL activity in the treated culture from 48.4% specific lysis to 10.2%, a reduction of 79%. This value was used as the control value in the above formula to determine % suppressor activity of the supernatants. collectedand assayed for HSV-SF activity. The nylon-woolpurified cell population produced HSV-SF as did the plastic nonadherent cells (Table 2) . Treatment with anti-Thy 1.2 antiserum and complement at day 0, followed by virus stimulation, also abrogated HSV-SF production. Together these results indicate that the production of HSV-SF requires T-cell participation.
Time course of suppression by the stimulated immune splenocyte supernatant fluids. In the preceding experiments, the HSV-SF was added at the initiation of the test cultures. In experiments in which HSV-SF was added to the test culture at different times, maximum suppression of CTL induction was observed only when HSV-SF was added during the first 24 h of incubation (Fig. 2) . This indicated either that the target of the suppressor factor was an early event in HSV-specific CTL induction or that the suppressive activity represented an afferent acting suppressor factor.
Genetic restriction of the activity of the suppressive supernatants. A characteristic in other systems of afferent acting suppressor factors is that the activity is genetically restricted (2) . To test for this in the present system, the HSV-SF generated by C3H/HeJ (H-2 )-stimulated immune splenocytes was assayed against C57BL/6 (H-2b) and BALB/C (H-2d) cultures. The results (Table 2) indicate that although HSV-SF sometimes exhibited genetic restriction in its activity (Table 3 , experiment 1), variations in the genetic restrictiveness were observed among batches of HSV-SF, implying the possibility of multiple suppressive factors. To separate the genetically restricted activity from nonrestricted activity, serum-free HSV-SF was fractionated on an S-200 gel filtration column. When the column fractions were assayed against syngeneic and allogeneic HSV-specific CTL induction and syngeneic influenza-specific CTL induction (Fig. 3) , HSV-stimulated immune splenocyte cultures at initiation. CTL activity against syngeneic and allogeneic targets was assayed on day 5 as described in Table 1 , footnote a. b The letter within parentheses indicates a different batch of C3H/HeJ (H2k)-generated suppressive supernatant used for a given experiment.
ND, Not done. Data represent tthe average of four replicates per experiment. Standard errors were routinely less than 5% of the mean values. The L targets were L929 cells infected with HSV-1 (L HSV). The E targets were EL4 thymoma cells infected with HSV-1 (E HSV). The A targets were BALB/ c 3T3 clone A31 cells infected with HSV-4 (A HSV).
several distinct peaks of nonspecific suppressor activity were observed. In addition, antigen-specific, genetically restricted suppressor activities were observed in the fractions corresponding to an apparent molecular weight of 90,000 to 150,000. When those fractions containing the (Fig. 3) were rechromatographed on the S-200 column. The eluted fractions were again assayed against C3H/HeJ HSV-specific CTL (0), C57BL/6 HSV-specific CTL (H), and C3H/HeJ influenzaspecific CTL (A) induction cultures. Specific 'tCr releases were similar to those reported in Fig. 3. antigen-specific major histocompatibility complex (MHC)-restricted suppressor activity were concentrated, rechromatographed on an S-200 gel, and assayed against C3H/HeJ HSV-specific CTL induction cultures, a single peak of activity at a molecular weight of 90,000 to 150,000 was observed. No suppressive activity was observed against either C57BL/6 HSV-specific CTL cultures or C3H/HeJ influenza-specific CTL cultures (Fig. 4) , confirming the suggested presence of an antigen-specific, genetically restricted suppressor factor in HSV-SF.
DISCUSSION
Suppressor cells (1, 13, 20, 22) and soluble factors (3, 6, 10, 23) are known to regulate the induction of alloantigenspecific CTL, but the role such regulatory elements play in virus-specific CTL induction is unknown. Previous evidence that HSV-specific CTL induction is regulated by a suppres- (11, 16, 18) . In the present report we provide direct evidence that induction of in vitro HSV-specific CTL is regulated by soluble suppressor factors produced by HSV-specific T lymphocytes (HSV-SF). HSV-SF were generated in cultures of HSV-immune splenocytes after viral stimulation. Similar factors were not produced by HSV-stimulated normal, HSV-stimulated influenza-immune, or unstimulated HSV-immune splenocytes, indicating that activation by specific antigen is required for both in vivo priming and in vitro activation to generate suppressor factors. From cell separation studies, T lymphocytes were shown necessary for HSV-SF production, but the role of other interacting cell types and the T-cell subset nature of producing cells require further investigation. Cultures which produced suppressor factors usually generated CTL, indicating that factor production failed to abrogate CTL induction in the factor-producing culture. Presumably this was because factor production occurred too late to regulate CTL. Thus HSV-SF levels were first detectable on day 3 and did not peak until day 5. To effect suppression and abrogate CTL, induction factors had to be added within 24 h of the initiation of culture.
Some batches of HSV-SF exhibited genetically restricted suppressor activity, whereas others inhibited CTL induction in a nonspecific fashion. These results indicated that HSV-SF might be heterogenous in composition. Support for this notion came from results of fractionation of HSV-SF by molecular sieve chromatography. Multiple peaks of suppressor activity were observed. Most of those peaks exhibited nonspecific activity, but the suppression mediated by the 90,000 to 150,000-molecular-weight fractions was antigen specific and genetically restricted.
Although antigen-specific regulation of CTL induction by suppressor cells was described previously (1, 20) , regulation by soluble factors was not antigen specific (3, 10, 23) . Thus the antigen-specific, genetically restricted suppressor factor regulating HSV-specific CTL induction that we observed represents a novel mechanism for CTL regulation. Antigenspecific, genetically restricted suppressor factors are involved in the regulation of antibody production, contact sensitivity, and delayed-type-hypersensitivity reactions, and similar factors act as suppressor signals between various subpopulations of T cells that comprise antigen-specific suppressor networks (reviewed in references 5 and 7). Our finding of an antigen-specific, genetically restricted suppressor factor in HSV-SF indicates that a similar suppressor network may be involved in the regulation of HSV-specific CTL induction. Furthermore, the antigen-specific suppressor networks were recently shown to culminate in the production of a nonspecific suppressor factor that mediates suppression (2, 24) . It is possible that the nonspecific factors described in this report may be part of the same suppressor network.
It is important to ascertain the mode of action of the specific and nonspecific suppressor factors. However, from analogy with alloantigen systems, we suspect that the target cells could be helper T lymphocytes known to be required for HSV-specific CTL induction (2, 19) . Thus the necessity to add factors within 24 h to obtain suppression also was observed in the alloantigen system (10, 23) . In the latter instance, helper T cells were identified as targets on the basis of cell separation analysis and because suppression could be overcome by the addition of helper cell products and cells (10, 22) . In our system we were able to inhibit some but not all of the suppressor activities by the addition of exogenous sources of IL-2-containing supernatant fluids from mitogenstimulated splenocyte cultures 
